BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33535306)

  • 21. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
    Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
    Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.
    Zhao GX; Xu YY; Weng SQ; Zhang S; Chen Y; Shen XZ; Dong L; Chen S
    Oncogene; 2019 Jun; 38(23):4574-4589. PubMed ID: 30742066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT/PI3K.
    Guo HM; Yang SH; Zhao SZ; Li L; Yan MT; Fan MC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4090-4097. PubMed ID: 30024596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXF2 inhibits proliferation, migration, and invasion of Hela cells by regulating Wnt signaling pathway.
    Zhang J; Zhang C; Sang L; Huang L; Du J; Zhao X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30249755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical cancer cell-derived Tie1 expression via PI3K/AKT signaling pathway promotes tumor progression.
    Wei Y; Yu P; Zhao Z; Sun C; Sun Q; Bai R; Gao W; Yang P
    Exp Cell Res; 2024 Jun; 439(1):114060. PubMed ID: 38719173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Over-expression of Hsa-miR-23b-3p suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of human cervical cancer CasKi cells].
    Hu J; Sun Z; Hu K; Tang M; Sun S; Fang Y; Yu H; Zhang Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Nov; 36(11):983-989. PubMed ID: 33210592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The mechanism of S100A7 inducing the migration and invasion in cervical cancer cells].
    Tian T; Hua Z; Kong Y; Wang LZ; Liu XY; Han Y; Zhou XM; Cui ZM
    Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):375-381. PubMed ID: 37188621
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.
    He JH; Chen JG; Zhang B; Chen J; You KL; Hu JM; Xu JW; Chen L
    Technol Cancer Res Treat; 2020; 19():1533033820936773. PubMed ID: 32618228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMQ‑T‑F2 suppresses migration of the human cervical cancer HeLa cells by reversing EMT via the PI3K/Akt signaling pathway.
    Dai B; Yu R; Fan M; Yang T; Wang B; Zhang Y
    Oncol Rep; 2019 Oct; 42(4):1451-1458. PubMed ID: 31364732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
    Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
    Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    Teng P; Jiao Y; Hao M; Tang X
    J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
    Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
    Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition.
    Li Q; Bao W; Fan Q; Shi WJ; Li ZN; Xu Y; Wu D
    Mol Med Rep; 2016 Oct; 14(4):3220-8. PubMed ID: 27573546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
    Wang F; Ruan XJ; Zhang HY
    Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.
    Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X
    Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of forkhead Box protein A1 on cell proliferation regulating and EMT of cervical carcinoma.
    Gu F; Li ZH; Wang CQ; Yuan QF; Yan ZM
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7189-7196. PubMed ID: 30468461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.